You are here:

budesonide 200mcg (Novolizer®) inhaler


Following an abbreviated submission

budesonide (Novolizer) inhaler is accepted for use within NHS Scotland for the treatment of persistent asthma in adults and children over 6 years of age.

Budesonide (Novolizer) inhaler offers an alternative to existing dry powder inhaled formulations of budesonide at a similar cost.

Drug Details

Drug Name: budesonide 200mcg (Novolizer®) inhaler
SMC Drug ID: 306/06
Manufacturer: Meda Pharmaceuticals Ltd
Indication: Asthma
BNF Category:
Sub Category: 3.2 Corticosteroids
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 11 September 2006